ArcherDX Says Natera Dragged Feet On Patent Filings
Genetic testing company Natera Inc. waited until competitor ArcherDX sunk millions into similar cancer testing products before filing for patents and suing ArcherDX for infringement, an "unreasonable" and "unexplained" delay that...To view the full article, register now.
Already a subscriber? Click here to view full article